Evidence map›Paper›PMID 16281070›Full record

ArticleLeukemia2006

The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.

H Gadner, G Masera, M Schrappe, T Eden, Y Benoit, C Harrison, J Nachman, C H Pui

Abstract readConference Proceedings
PubMed Publisher
In one paragraph

Article in Leukemia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

H GadnerBerlin-Frankfurt-Münster Study Group and St Anna Children's Hospital, Vienna, Austria. helmut.gadner@stanna.at
G Masera
M Schrappe
T Eden
Y Benoit
C Harrison
J Nachman
C H Pui

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Whole GenomeU01GM061393 · NIGMS · UNIVERSITY OF CHICAGO · PI COX, NANCY J, DOLAN, MARY EILEEN · 2000 to 2014
$39.0M
PEDIATRIC ONCOLOGY GROUP STATISTICAL OFFICEU10CA029139 · NCI · UNIVERSITY OF FLORIDA · PI DEVIDAS, MEENAKSHI · 1985 to 2002
$7.3M
P450 METABOLISM OF EPIPODOPHYLLOTOXINS IN CHILDRENR01CA051001 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V. · 1996 to 2006
$2.7M
PEDICATRIC ONCOLOGY RESEARCH BASEU10CA037379 · NCI · WASHINGTON UNIVERSITY · PI POLLOCK, BRAD H. · 1985 to 2001
$1.1M
PEDIATRIC ONCOLOGY GROUP PARTICIPATIONU10CA031566 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PUI, CHING-HON · 1985 to 2002
$668k
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDRENR29CA051001 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V. · 1990 to 1994
–
NCI NIH HHS CA-21765NCI NIH HHS CA-29139NCI NIH HHS CA-31566NCI NIH HHS CA-37379NCI NIH HHS CA-51001NCI NIH HHS CA-78824NIGMS NIH HHS GM-61374NIGMS NIH HHS GM-61393
6 · The paper itself

Abstract

The International Acute Lymphoblastic Leukemia Working Group, the so-called 'Ponte di Legno Workshop' has led to substantial progress in international collaboration in leukemia research. On April 27-28, 2005, the 8th Meeting was held in Vienna, Austria, to continue the discussions about special common treatment elements in randomized clinical trials, ethical and clinical aspects of therapy. Furthermore, collaborative projects of clinical relevance with special emphasis on rare genetic subtypes of Childhood ALL were established. The following report summarizes the achievements and aspects of possible future cooperation.

Indexed as

AustriaHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaRandomized Controlled Trials as TopicRisk Factors

Identifiers

PMID16281070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.